0

Radiation generates cancer STEM cells from cancer cells.

Dr. Weeks’ Comment: Another “oops” moment:  radiation kills cancer TUMOR cells but NOT the cancer STEM cells!

 


Radiation Treatment Generates Cancer Stem Cells from Less Aggressive Breast Cancer Cells, Study Suggests

 

ScienceDaily (Feb. 13, 2012) — Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don’t respond well to chemotherapy.

Now, researchers with the UCLA Department of Radiation Oncology at UCLA’s Jonsson Comprehensive Cancer Center report for the first time that radiation treatment — despite killing half of all tumor cells during every treatment — transforms other cancer cells into treatment-resistant breast cancer stem cells.

The generation of these breast cancer stem cells counteracts the otherwise highly efficient radiation treatment. If scientists can uncover the mechanisms and prevent this transformation from occurring, radiation treatment for breast cancer could become even more effective, said study senior author Dr. Frank Pajonk, an associate professor of radiation oncology and Jonsson Cancer Center researcher.

“We found that these induced breast cancer stem cells (iBCSC) were generated by radiation-induced activation of the same cellular pathways used to reprogram normal cells into induced pluripotent stem cells (iPS) in regenerative medicine,” said Pajonk, who also is a scientist with the Eli and Edythe Broad Center of Regenerative Medicine at UCLA. “It was remarkable that these breast cancers used the same reprogramming pathways to fight back against the radiation treatment.”

The study recently appeared in the early online edition of the peer-reviewed journal Stem Cells.

“Controlling the radiation resistance of breast cancer stem cells and the generation of new iBCSC during radiation treatment may ultimately improve curability and may allow for de-escalation of the total radiation doses currently given to breast cancer patients, thereby reducing acute and long-term adverse effects,” the study states.

There are very few breast cancer stem cells in a larger pool of breast cancer cells. In this study, Pajonk and his team eliminated the smaller pool of breast cancer stem cells and then irradiated the remaining breast cancer cells and placed them into mice.

Using a unique imaging system Pajonk and his team developed to visualize cancer stem cells, the researchers were able to observe their initial generation into iBCSC in response to the radiation treatment. The newly generated iBCSC were remarkably similar to breast cancer stem cells found in tumors that had not been irradiated, Pajonk said.

The team also found that the iBCSC had a more than 30-fold increased ability to form tumors compared to the non-irradiated breast cancer cells from which they originated.

Pajonk said that the study unites the competing models of clonal evolution and the hierarchical organization of breast cancers, as it suggests that undisturbed, growing tumors maintain a small number of cancer stem cells. However, if challenged by various stressors that threaten their numbers, including ionizing radiation, the breast cancer cells generate iBCSC that may, together with the surviving cancer stem cells, repopulate the tumor.

“What is really exciting about this study is that it gives us a much more complex understanding of the interaction of radiation with cancer cells that goes far beyond DNA damage and cell killing,” Pajonk said. “The study may carry enormous potential to make radiation even better.”

Pajonk stressed that breast cancer patients should not be alarmed by the study findings and should continue to undergo radiation if recommended by their oncologists.

“Radiation is an extremely powerful tool in the fight against breast cancer,” he said. “If we can uncover the mechanism driving this transformation, we may be able to stop it and make the therapy even more powerful.”

This study was funded by the National Cancer Institute, the California Breast Cancer Research Program and the Department of Defense.

 

Journal Reference:

1.Chann Lagadec, Erina Vlashi, Lorenza Della Donna, Carmen Dekmezian and Frank Pajonk. Radiation-induced Reprograming of Breast Cancer Cells. Stem Cells, 10 FEB 2012 DOI: 10.1002/stem.1058

Print Friendly
Filed in: Cancer, Cancer STEM cells

Recent Posts

© 2014 WeeksMD. All rights reserved.
WeeksMD.com is a resource provided by Dr. Bradford Weeks, M.D.

WELCOME!

The information contained on these web pages is derived from Dr. Weeks’ years of clinical experience and his review of scientific literature. However, these ideas and information are for your education and entertainment only. They are positively not intended to be a substitute for careful medical evaluation and treatment by a competent, licensed personal health care professional. Dr. Weeks and his associates do not recommend changing any current medications or adding any new therapies without personally consulting a fully qualified physician. Dr. Weeks and his staff specifically disclaim any liability arising directly or indirectly from information contained on these Web pages.

Varying and even conflicting views are held by other segments of the medical profession. The information presented on these Web pages is intended to be educational and entertaining in nature and is not intended as a basis for diagnosis or treatment. This information is current at the time of posting on the World Wide Web, and is published and distributed as a courtesy to the public.

www.seoda.info www.grafiktasarim.info www.webtasarimseo.info www.seotasarim.info www.grafikseo.info www.googledanismani.info www.devteknoloji.net www.eticaretci.org www.e-ticaretim.org www.seodanismani.biz www.farklibakis.com www.grafblog.com www.guvenliukash.info www.sagliklizayifla.ws www.eokul.ws www.simdisatinal.com www.un-mongolia.com www.un-ngls.com www.unvienna.net